2018
A documentary exploring plant medicines and psychedelics, with an attempt to show a different perspective than the current mainstream narrative. Some of them used for thousands of years as ...
84 min
CLEAR ALL
After decades in the shadows, new studies are looking at psychedelic drugs and their efficacy at treating a variety of psychological issues, including depression.
A renaissance is underway in the scientific study of psychedelics, both as a mode of therapy for mental illness and as a tool for understanding the mind.
How could LSD and psilocybin help with mental health, palliative care and addictive behaviours? What was the point of a psilocybin mushroom evolving the way that it did? Michael Pollan explores the “second wave” of international research and discusses what psychedelic drugs may teach us about...
As one of our most brilliant and clear-eyed explorers of such topics as plant intelligence and how we feed ourselves, Michael will share his luminous insights from what began as investigative reportage and became a very personal interior journey into the mystery of consciousness and the nature of...
1
The Hopkins laboratory has also conducted a recent series of internet survey studies characterizing the effects hallucinogen-occasioned mystical experiences, challenging experiences, and effects on substance abuse.
Psychedelics were the subject of serious medical research in the 1940s to the 1960s, when many scientists believed some of the mind-bending compounds held tremendous therapeutic promise for treating a number of conditions including severe mental health problems and alcohol addiction.
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
Roland R. Griffiths, Ph.D. is a psychopharmacologist who serves as a professor and research coordinator at the Johns Hopkins University School of Medicine. This interview was captured during the Psychedemia conference at the University of Pennsylvania in September 2012.